<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210211050329N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-03-02</date_registration>
      <primary_sponsor>Azarbaijan Shahid Madani University</primary_sponsor>
      <public_title>Effect of rTMS on Cognitive Function of Depressive Disorder</public_title>
      <acronym></acronym>
      <scientific_title>7	Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on depression severity, response inhibition, cognitive flexibility and visuo-spatial memory in patients with Depressive Disorder</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-03-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/54467</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization method: simple
Randomization unit: individual
Randomization tool: In separate sheets, we will write the names of all the participants in the study and will put them in a container, and then randomly will pick the names and will add the first one to the list of the unilateral stimulation group, the second to the list of the bilateral stimulation group, and the third to the control group list. We will continue this until the last person, Blinding description: Participants will not be explained whether they are in the intervention group or in the control group (blinding takes place), but due to the difference in stimulation areas in the two intervention groups, blinding between intervention groups is not possible for participants.
Due to the difference in stimulation areas in the intervention groups and the difference in the stimulation angle in the control group and the intervention groups, blinding is impossible for the researcher. However, the data analyzer will be blind because he will receive only the list of data specified by a different code. And the person does not know which code is for which group—for example, the number 25 for a unilateral group. The number 35 will be assigned to the control group and the number 15 to the bilateral group, which in data analysis, the analyst will not be aware of the allocation of these numbers to the groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Depressive Disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:  Stimulation will be performed by using a Magstim super-rapid magnetic stimulator (Wales, UK). The unilateral group will receive stimulation of Left DLPFC (20Hz, 5s in each train, 2100 pulses, and 85% of Motor Threshold) for 10 sessions during 2 weeks( 5 sessions each week). The coil will be placed at a 45-degree angle on the patient's scalp. Intervention 2: Intervention group 2: Stimulation will be performed by using a Magstim super-rapid magnetic stimulator (Wales, UK). The bilateral group will receive stimulation of left DLPFC (20Hz, 5s in each train, 1400 pulses, and 85% of Motor Threshold), followed by Right DLPFC stimulation (1Hz, 10s in each train, 700 pulses, and 110% of Motor Threshold) for 10 sessions during 2 weeks( 5 sessions each week). The coil will be placed at a 45-degree angle on the patient's scalp. Intervention 3: Control group:  In the control group, we will perform artificial stimulation and for 10 sessions for 2 weeks( 5 sessions each week), but the coil will be placed at a 90-degree angle on the patient's scalp. So they will not receive any stimulation.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Asgharian Asl</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tabriz. valiar</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5158944399</zip>
        <telephone>+98 910 402 0414</telephone>
        <email>fatemeh.asgharian@azaruni.ac.ir</email>
        <affiliation>Azarbaijan Shahid Madani University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Asgharian asl</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Valiasr, Tabriz</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5158944399</zip>
        <telephone>+98 41 3145 2406</telephone>
        <email>fatemeh.asgharian@azaruniv.ac.ir</email>
        <affiliation>Azarbaijan Shahid Madani University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Being right-hand
Age between 25-45
Having physical health</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Being pregnant
Having metal, prosthesis, implant or pacemaker
Dependence on psychotropic substances
History of Trauma or seizures in the individual or family
Having other psychological disorders</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F32.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Major depressive disorder, single episode, severe without psychotic features</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:  Stimulation will be performed by using a Magstim super-rapid magnetic stimulator (Wales, UK). The unilateral group will receive stimulation of Left DLPFC (20Hz, 5s in each train, 2100 pulses, and 85% of Motor Threshold) for 10 sessions during 2 weeks( 5 sessions each week). The coil will be placed at a 45-degree angle on the patient's scalp.</i_keyword>
      <i_keyword>Intervention group 2: Stimulation will be performed by using a Magstim super-rapid magnetic stimulator (Wales, UK). The bilateral group will receive stimulation of left DLPFC (20Hz, 5s in each train, 1400 pulses, and 85% of Motor Threshold), followed by Right DLPFC stimulation (1Hz, 10s in each train, 700 pulses, and 110% of Motor Threshold) for 10 sessions during 2 weeks( 5 sessions each week). The coil will be placed at a 45-degree angle on the patient's scalp.</i_keyword>
      <i_keyword>Control group:  In the control group, we will perform artificial stimulation and for 10 sessions for 2 weeks( 5 sessions each week), but the coil will be placed at a 90-degree angle on the patient's scalp. So they will not receive any stimulation.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Depression score in Beck questionnaire and clients' performance in cognitive functions of response inhibition, cognitive flexibility, and visual-spatial memory. Timepoint: Before the intervention and after two weeks. Method of measurement: By Beck Depression questionnaire and Clients' Performance in Cognitive Tasks of Go-Go, Corsi, and Wisconsin.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Azarbaijan Shahid Madani University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-02-17</approval_date>
        <contact_name>Ethics committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Abresan. Tabriz Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
